Paper41208856
Enhanced pharmacokinetic and therapeutic of GSH-responsive mPEG-b-P(HPMA)-SGI1776 conjugate for osteosarcoma.
Shi X and 6 others. Front Pharmacol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Enhanced pharmacokinetic and therapeutic of GSH-responsive mPEG-b-P(HPMA)-SGI1776 conjugate for osteosarcoma. Papers, record 41208856. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41208856
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhanced pharmacokinetic and therapeutic of GSH-responsive mPEG-b-P(HPMA)-SGI1776 conjugate for osteosarcoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29313017 | Anticancer nanoparticulate polymer-drug conjugate. | Bioeng Transl Med | 2016 | https://conductscience.org/library/papers/29313017 | PubMed |
| 2 | 19491032 | HPMA-based polymer conjugates with drug combination. | Eur J Pharm Sci | 2009 | https://conductscience.org/library/papers/19491032 | PubMed |
| 3 | 38169995 | Combination of Chlorambucil and Mercaptopurine Show Effective Anti-Cancer Effects in Mice Model. | Int J Nanomedicine | 2023 | https://conductscience.org/library/papers/38169995 | PubMed |
| 4 | 36214740 | Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms. | Expert Opin Drug Deliv | 2022 | https://conductscience.org/library/papers/36214740 | PubMed |
| 5 | 40740117 | Tumor-responsive nanomedicines for cancer therapy: design principles and therapeutic advances. | Biomed Mater | 2025 | https://conductscience.org/library/papers/40740117 | PubMed |
| 6 | 39247254 | Biodegradable Zwitterionic Polymers as PEG Alternatives for Drug Delivery. | J Polym Sci (2020) | 2024 | https://conductscience.org/library/papers/39247254 | PubMed |
| 7 | 28681981 | ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy. | Adv Mater | 2017 | https://conductscience.org/library/papers/28681981 | PubMed |
| 8 | 29296558 | Advances in limb salvage treatment of osteosarcoma. | J Bone Oncol | 2018 | https://conductscience.org/library/papers/29296558 | PubMed |
| 9 | 23673544 | Osteosarcoma: review of the various types with emphasis on recent advancements in imaging. | Semin Musculoskelet Radiol | 2013 | https://conductscience.org/library/papers/23673544 | PubMed |
| 10 | 30270668 | Regulation of insulin resistance and glucose metabolism by interaction of PIM kinases and insulin receptor substrates. | Arch Physiol Biochem | 2020 | https://conductscience.org/library/papers/30270668 | PubMed |
| 11 | 28260965 | Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles. | J Nanopart Res | 2017 | https://conductscience.org/library/papers/28260965 | PubMed |
| 12 | 30718520 | PIM kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/30718520 | PubMed |
| 13 | 29191047 | Stealth lipid polymer hybrid nanoparticles loaded with rutin for effective brain delivery - comparative study with the gold standard (Tween 80): optimization, characterization and biodistribution. | Drug Deliv | 2017 | https://conductscience.org/library/papers/29191047 | PubMed |
| 14 | 24925051 | Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity. | Mod Pathol | 2014 | https://conductscience.org/library/papers/24925051 | PubMed |
| 15 | 30546919 | Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics. | J Pharm Investig | 2018 | https://conductscience.org/library/papers/30546919 | PubMed |
| 16 | 34927373 | Stimuli-Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy. | Adv Sci (Weinh) | 2022 | https://conductscience.org/library/papers/34927373 | PubMed |
| 17 | 27783140 | Lower limb reconstruction in tumor patients using modular silver-coated megaprostheses with regard to perimegaprosthetic joint infection: a case series, including 100 patients and review of the literature. | Arch Orthop Trauma Surg | 2017 | https://conductscience.org/library/papers/27783140 | PubMed |
| 18 | 40164682 | Pim1 promotes the maintenance of bone homeostasis by regulating osteoclast function. | Exp Mol Med | 2025 | https://conductscience.org/library/papers/40164682 | PubMed |
| 19 | 28195032 | pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms. | Drug Deliv | 2017 | https://conductscience.org/library/papers/28195032 | PubMed |
| 20 | 33662457 | Design and synthesis of a novel mitochondria-targeted osteosarcoma theranostic agent based on a PIM1 kinase inhibitor. | J Control Release | 2021 | https://conductscience.org/library/papers/33662457 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41208856
GET https://conductscience.org/api/papers/v1/41208856/references?page=2